Jiangsu Hengrui Pharmaceuticals Co., Ltd

Hengrui Medicine is a prominent pharmaceutical corporation situated in China, focusing on the exploration, production, manufacturing, and marketing of groundbreaking and superior healthcare goods. It underwent restructuring into a joint-stock company in 1997 and was subsequently listed on the Shanghai Stock Exchange under stock code 600276 in 2000. With a market capitalization exceeding 55 billion USD, the company is ranked among the top 30 pharmaceutical firms globally and employs over 21,900 personnel worldwide. Hengrui is recognized as a pioneer in the field of cancer medications, contrast agents, and surgical innovations.

Products & Services

Atracurium Besylate

Azelastine Hydrochloride

Azelastine Hydrochloride Non Sterile Bulk Drug Substance

Bupivacaine

Bupivacaine Base

Sites

Jiangsu Hengrui Medicine

Address

38 Huanghe Road Economic & Technological Development Zone Lianyungang Jiangsu 222047 China

JIANGSU HENGRUI MEDICINE CO. LTD

Audited

Country

People's Republic of China

Address

Huang He Lu, Huang Pu Qu, Shang Hai Shi, China